Eliem Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Eliem Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Eliem Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eliem Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $581k | 45k | 13.04 |
| 2025-03-31 | $30k | 25k | 1.22 |
| 2024-12-31 | $57k | 32k | 1.80 |
| 2024-09-30 | $141k | 28k | 5.09 |
| 2024-06-30 | $59k | 8.2k | 7.11 |